It is a pleasure to invite you to this meeting, which is organised by the RADIATE-ITN and will take place at the Institut Curie Paris, France on 12 October 2018. RADIATE is an innovative training network funded by the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No: 642623.
This meeting is part of Outreach activities by the RADIATE-ITN and is aimed particularly at young researchers. With talks by leading international investigators and poster sessions dedicated to research in the field of radiation biology and oncology, this promises to be a highly interactive and informative meeting.
The theme of IMSCM2018 will be the use of radiation biology in the treatment of cancer.
Topics of interest: Tumour Microenvironment; DNA Repair; Immune Response; Innovative Therapies.
Keynote Speakers: Thomas Helleday, Karolinska Institutet; Rob Coppes, Groningen University Medical Center; Andy Minn, University of Pennsylvania; Mark Dewhirst, Duke University; Mark de Ridder, Vrije Universiteit Brussel; Marie Dutreix, Institut Curie; Ester Hammond, University of Oxford; Sylvia Formenti, Weill Cornell Medical College.
Further details of the Programme, including the Keynote speakers can be found on our conference website.
Deadline for early bird registration: 30 April 2018
Deadline for abstract submission: 13 August 2018
Deadline for registration: 15 September 2018
Abstract submission can be found on our website.
All abstracts must be sent to email@example.com. For any enquiries regarding the programme, and all general enquiries, please contact: firstname.lastname@example.org
We look forward to seeing you at IMSCM2018 in Paris!
Affiche du séminaire
Séminaire proposé par Marie Dutreix
Tags: Chemistry, Radioactivity, Physics, Nobel Prize, Nobel laureates in Physics, Sklodowska, Marie Curie, Curie, Radium, IEEE Marie Sklodowska-Curie Award, Pierre Curie
Annonce publiée le 20-07-2018